SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

BOSTON and ROLLE, Switzerland, Aug. 28, 2024 /PRNewswire/ -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced presentations at the 22^nd Annual Morgan Stanley Healthcare Conference and the 9^th Annual TD Cowen FutureHealth Conference in early September.

Chief Financial Officer and Chief Operating Officer, Ross Muken, will present at the 22^nd Annual Morgan Stanley Healthcare Conference in New York City on Wednesday, September 4, 2024, at 1:50 p.m. EDT.

The following week, co-Founder and Chief Executive Officer, Dr. Jurgi Camblong, will join a Panel Discussion on AI in Healthcare at the 9^th Annual TD Cowen FutureHealth Conference in New York City on Tuesday, September 10, 2024, at 3:15 p.m. EDT.

The presentations will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDM™, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions.  For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.

SOURCE SOPHiA GENETICS